What is the current stock price of Brain+ A/S (BRAINP.CO)?

As of the latest market data, Brain+ A/S (BRAINP.CO) is trading at $0.00. The stock has seen a loss of undefined% today.

Does Brain+ A/S (BRAINP.CO) pay a dividend?

Based on current data, Brain+ A/S does not have a confirmed active dividend policy.

What is the market cap of Brain+ A/S?

The current market capitalization of Brain+ A/S (BRAINP.CO) is approximately unavailable.

BRAINP.CO

Brain+ A/S·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Brain+ A/S develops digital therapeutics for Alzheimer's and dementia. The company develops cognitive stimulation therapy (CST), a therapy that treats the main symptoms of dementia; Computerized Cognitive Training, a cognitive training method for patients with mild cognitive impairment; and Starry Night, memory test for early detection and monitoring of Alzheimer's. In addition, it develops an interface for clinicians to track and trace the patient's treatment progress. The company was incorporated in 2012 and is based in Copenhagen, Denmark. Brain+ A/S was formerly a subsidiary of Brain+ Holding ApS.

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Employees

IPO Date

2021-10-07

Beta

-0.50

Websitewww.brain-plus.com↗